ScreenPoint Medical Highlights Transpara Breast AI at RSNA 2025
ScreenPoint Medical is presenting its Transpara Breast AI suite at RSNA 2025, showcasing research that underscores its impact on cancer detection and workflow efficiency. The AI system, used in over 30 countries, has processed more than 11 million mammograms and is part of major clinical studies including MASAI and the upcoming PRISM trial.